600 related articles for article (PubMed ID: 29319278)
21. Topical application of cyclosporin A induces rapid-remodeling of damaged anagen hair follicles produced in cyclophosphamide administered mice.
Shirai A; Tsunoda H; Tamaoki T; Kamiya T
J Dermatol Sci; 2001 Sep; 27(1):7-13. PubMed ID: 11457638
[TBL] [Abstract][Full Text] [Related]
22. Androgenetic alopecia and current methods of treatment.
Bienová M; Kucerová R; Fiurásková M; Hajdúch M; Koláŕ Z
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):5-8. PubMed ID: 15818439
[TBL] [Abstract][Full Text] [Related]
23. Minoxidil use in dermatology, side effects and recent patents.
Rossi A; Cantisani C; Melis L; Iorio A; Scali E; Calvieri S
Recent Pat Inflamm Allergy Drug Discov; 2012 May; 6(2):130-6. PubMed ID: 22409453
[TBL] [Abstract][Full Text] [Related]
24. Topical minoxidil for hair regrowth.
Vanderveen EE; Ellis CN; Kang S; Case P; Headington JT; Voorhees JJ; Swanson NA
J Am Acad Dermatol; 1984 Sep; 11(3):416-21. PubMed ID: 6384289
[TBL] [Abstract][Full Text] [Related]
25. Retinoids: compounds important to hair growth.
Terezakis NK; Bazzano GS
Clin Dermatol; 1988; 6(4):129-31. PubMed ID: 3063367
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
[TBL] [Abstract][Full Text] [Related]
27. Preparation of topical bimatoprost with enhanced skin infiltration and
Subedi L; Pandey P; Shim JH; Kim KT; Cho SS; Koo KT; Kim BJ; Park JW
Drug Deliv; 2022 Dec; 29(1):328-341. PubMed ID: 35040730
[TBL] [Abstract][Full Text] [Related]
28. Low-dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patients.
Goren A; Sharma A; Dhurat R; Shapiro J; Sinclair R; Situm M; Kovacevic M; Lukinovic Skudar V; Goldust M; Lotti T; McCoy J
Dermatol Ther; 2018 Nov; 31(6):e12741. PubMed ID: 30226287
[TBL] [Abstract][Full Text] [Related]
29. Topical minoxidil: review of efficacy and safety.
Katz HI
Cutis; 1989 Jan; 43(1):94-8. PubMed ID: 2644080
[TBL] [Abstract][Full Text] [Related]
30. A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men.
Hillmann K; Garcia Bartels N; Kottner J; Stroux A; Canfield D; Blume-Peytavi U
Skin Pharmacol Physiol; 2015; 28(5):236-44. PubMed ID: 25765348
[TBL] [Abstract][Full Text] [Related]
31. Oral minoxidil treatment for hair loss: A review of efficacy and safety.
Randolph M; Tosti A
J Am Acad Dermatol; 2021 Mar; 84(3):737-746. PubMed ID: 32622136
[TBL] [Abstract][Full Text] [Related]
32. New ethanol and propylene glycol free gel formulations containing a minoxidil-methyl-β-cyclodextrin complex as promising tools for alopecia treatment.
Lopedota A; Cutrignelli A; Denora N; Laquintana V; Lopalco A; Selva S; Ragni L; Tongiani S; Franco M
Drug Dev Ind Pharm; 2015 May; 41(5):728-36. PubMed ID: 24650036
[TBL] [Abstract][Full Text] [Related]
33. Topical minoxidil therapy for hereditary male pattern alopecia.
Roenigk HH; Pepper E; Kuruvilla S
Cutis; 1987 Apr; 39(4):337-42. PubMed ID: 3556042
[TBL] [Abstract][Full Text] [Related]
34. Cyclic dynamics of hair follicles and the effect of minoxidil on the bald scalps of stumptailed macaques.
Uno H; Cappas A; Schlagel C
Am J Dermatopathol; 1985 Jun; 7(3):283-97. PubMed ID: 4051135
[No Abstract] [Full Text] [Related]
35. Minoxidil and its use in hair disorders: a review.
Suchonwanit P; Thammarucha S; Leerunyakul K
Drug Des Devel Ther; 2019; 13():2777-2786. PubMed ID: 31496654
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study.
Hossein Mostafa D; Samadi A; Niknam S; Nasrollahi SA; Guishard A; Firooz A
J Pharm Pharm Sci; 2021; 24():191-199. PubMed ID: 33909554
[TBL] [Abstract][Full Text] [Related]
37. A review of the treatment of male pattern hair loss.
York K; Meah N; Bhoyrul B; Sinclair R
Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
[No Abstract] [Full Text] [Related]
38. [Androgenetic alopecia. Current aspects of a common phenotype].
Hanneken S; Ritzmann S; Nöthen MM; Kruse R
Hautarzt; 2003 Aug; 54(8):703-12. PubMed ID: 12942184
[TBL] [Abstract][Full Text] [Related]
39. Potential synergistic effects of human placental extract and minoxidil on hair growth-promoting activity in C57BL/6J mice.
Kwon TR; Oh CT; Park HM; Han HJ; Ji HJ; Kim BJ
Clin Exp Dermatol; 2015 Aug; 40(6):672-81. PubMed ID: 25787854
[TBL] [Abstract][Full Text] [Related]
40. Comparative Evaluation of the Clinical Efficacy of PRP-Therapy, Minoxidil, and Their Combination with Immunohistochemical Study of the Dynamics of Cell Proliferation in the Treatment of Men with Androgenetic Alopecia.
Pakhomova EE; Smirnova IO
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
